GlassScriptPhysician profile
Indijana Cicona
NPI 1568239788
$2,271.73
in general payments reported to CMS, 2019-2025
20 companies · $1,401 in 2025
The $1,401 reported for 2025 was more than what 90% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $871 · 2025: $1,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735 · Education: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.88 |
| Education | $536.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $432.46 | 2024-2025 | Dupixent, Libtayo |
| Sun Pharmaceutical Industries INC. | $320.46 | 2024-2025 | |
| Abbvie INC. | $266.37 | 2024-2025 | |
| Janssen Biotech, INC. | $226.64 | 2024-2025 | Tremfya |
| Genzyme Corporation | $194.40 | 2024-2025 | |
| Incyte Corporation | $124.24 | 2024-2025 | Opzelura |
| Leo Pharma INC. | $124.22 | 2024-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $111.70 | 2025 | Nemluvio |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $63.53 | 2024-2025 | |
| Ucb, INC. | $60.52 | 2024-2025 | Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.60 | 2024 | Siliq, Duobrii, Targretin |
| Lilly USA, LLC | $38.05 | 2024-2025 | Taltz, Ebglyss |
| E.R. Squibb & Sons, L.L.C. | $33.98 | 2025 | Sotyktu |
| Organogenesis INC. | $32.57 | 2025 | Via Matrix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.63 | 2025 | |
| Janssen Pharmaceuticals, INC | $26.34 | 2025 | Tremfya |
| Convatec INC. | $17.10 | 2025 | |
| Dermavant Sciences, INC. | $16.15 | 2024 | Vtama |
| Arcutis Biotherapeutics, INC. | $15.77 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indijana Cicona listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.